Kathryn has a BSc in Biology and PhD in Molecular Microbiology from Imperial College, London. She has over 16 years' experience in medical communications and strategic planning and has partnered with both Global and European Pharmaceutical companies across a range of therapeutic areas, with a particular focus on oncology.

Kathryn has expertise in the strategic design and implementation of innovative, multichannel communication programmes including scientific platforms. She also holds extensive experience in the design and implementation of best practice training sessions and workshops.

Kathryn has worked with Envision Pharma Group Limited since 2016 and was a founding member of the leadership team that established the Wilmslow office and the Alligent Europe division which specializes in supporting strategic planning with Medical Affairs teams.